Crossmark

Unlocking the potential of THR-β agonist therapies: resmetirom’s chemistry, biology, and patent insights

Published Online: 2025-03-11

Authors

Dahiya, Khushi

Palkar, Mahesh

Sharma, Sanjay
License Information

Text and Data Mining valid from 2025-03-11

Version of Record valid from 2025-03-11
More Information

Article History

Received: 22 January 2025

Accepted: 3 February 2025

First Online: 11 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current